Literature DB >> 3001699

p27x-III and p21x-III, proteins encoded by the pX sequence of human T-cell leukemia virus type I.

T Kiyokawa, M Seiki, S Iwashita, K Imagawa, F Shimizu, M Yoshida.   

Abstract

Human T-cell leukemia virus type I (HTLV-I) is an etiological agent of adult T-cell leukemia and has a unique sequence, pX, that contains four possible open reading frames, I-IV. p40x was previously identified as the gene product of frame IV (x-lor) and was suggested to mediate transcriptional trans-activation of the viral long terminal repeats. We have identified two pX gene products, p27x-III and p21x-III, encoded by frame III, which mostly overlapped frame IV. These proteins were detected with rabbit antiserum against the synthetic peptide predicted from the 3' end of frame III. p27x-III is phosphorylated in cultured cells, and the phosphoprotein (pp27x-III) is localized in nuclei; some pp27x-III was tightly bound to nuclear components. p27x-III was detected in a number of cell lines that express other viral antigens, including a cell line previously reported to express only p40x as a viral protein. The function(s) of p27x-III and p21x-III is not known, but the tight binding of pp27x-III to nuclear components suggests that it is associated with regulation of viral gene expression.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001699      PMCID: PMC390915          DOI: 10.1073/pnas.82.24.8359

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Identification of the putative transforming protein of the human T-cell leukemia viruses HTLV-I and HTLV-II.

Authors:  D J Slamon; K Shimotohno; M J Cline; D W Golde; I S Chen
Journal:  Science       Date:  1984-10-05       Impact factor: 47.728

2.  Structure of 3' terminal region of type II human T lymphotropic virus: evidence for new coding region.

Authors:  W A Haseltine; J Sodroski; R Patarca; D Briggs; D Perkins; F Wong-Staal
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

3.  Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells.

Authors:  M Seiki; R Eddy; T B Shows; M Yoshida
Journal:  Nature       Date:  1984 Jun 14-20       Impact factor: 49.962

4.  Identification of envelope glycoprotein encoded by env gene of human T-cell leukemia virus.

Authors:  S Hattori; K Imagawa; F Shimizu; E Hashimura; M Seiki; M Yoshida
Journal:  Gan       Date:  1983-12

5.  Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease.

Authors:  M Yoshida; M Seiki; K Yamaguchi; K Takatsuki
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Identification of gag and env gene products of human T-cell leukemia virus (HTLV).

Authors:  S Hattori; T Kiyokawa; K Imagawa; F Shimizu; E Hashimura; M Seiki; M Yoshida
Journal:  Virology       Date:  1984-07-30       Impact factor: 3.616

7.  Antigens encoded by the 3'-terminal region of human T-cell leukemia virus: evidence for a functional gene.

Authors:  T H Lee; J E Coligan; J G Sodroski; W A Haseltine; S Z Salahuddin; F Wong-Staal; R C Gallo; M Essex
Journal:  Science       Date:  1984-10-05       Impact factor: 47.728

8.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

Authors:  J G Sodroski; C A Rosen; W A Haseltine
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

9.  Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line.

Authors:  P Clapham; K Nagy; R Cheingsong-Popov; M Exley; R A Weiss
Journal:  Science       Date:  1983-12-09       Impact factor: 47.728

10.  Rat lymphoid cell lines with human T cell leukemia virus production. I. Biological and serological characterization.

Authors:  M Tateno; N Kondo; T Itoh; T Chubachi; T Togashi; T Yoshiki
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

View more
  76 in total

1.  Seroprevalence and demographic characteristics of HTLV-I among blood donors in Taiwan: 1996-1999.

Authors:  S C Lu; C L Kao; L T Chin; J W Chen; C M Yang; J H Chang; S C Hsu; A C Chang; B H Chen
Journal:  Int J Hematol       Date:  2001-10       Impact factor: 2.490

2.  Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I.

Authors:  I J Koralnik; A Gessain; M E Klotman; A Lo Monico; Z N Berneman; G Franchini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

3.  The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation.

Authors:  J Fujisawa; M Toita; T Yoshimura; M Yoshida
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Studies of heterologous promoter trans-activation by the HTLV-II tax protein.

Authors:  J L Williams; A J Cann; T Leff; P Sassone-Corsi; I S Chen
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

Review 5.  Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Authors:  Michael D Lairmore; Lee Silverman; Lee Ratner
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

6.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.

Authors:  Y Takebe; M Seiki; J Fujisawa; P Hoy; K Yokota; K Arai; M Yoshida; N Arai
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

7.  Mutational analysis of the human T-cell leukemia virus type I trans-acting rex gene product.

Authors:  L Hofer; I Weichselbraun; S Quick; G K Farrington; E Böhnlein; J Hauber
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

8.  Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance.

Authors:  I Weichselbraun; J Berger; M Dobrovnik; H Bogerd; R Grassmann; W C Greene; J Hauber; E Böhnlein
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

9.  Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence.

Authors:  K T Jeang; I Boros; J Brady; M Radonovich; G Khoury
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

Review 10.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.